{"protocolSection": {"identificationModule": {"nctId": "NCT04197180", "orgStudyIdInfo": {"id": "CREC 2019.490-T"}, "organization": {"fullName": "Chinese University of Hong Kong", "class": "OTHER"}, "briefTitle": "Hybrid APC for Gastric Low Grade Intraepithelial Neoplasia", "officialTitle": "HybridAPC for the Treatment of Gastric Low Grade Intraepithelial Neoplasia (LGIN): a Prospective, Multi-center Study", "acronym": "HybridAPC"}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Philip Wai Yan CHIU", "investigatorTitle": "Professor", "investigatorAffiliation": "Chinese University of Hong Kong"}, "leadSponsor": {"name": "Chinese University of Hong Kong", "class": "OTHER"}, "collaborators": [{"name": "Nanfang Hospital, Southern Medical University", "class": "OTHER"}, {"name": "Shenzhen Hospital of Southern Medical University", "class": "OTHER"}, {"name": "The Fifth Affiliated Hospital of Zunyi Medical College", "class": "OTHER"}]}, "descriptionModule": {"briefSummary": "This cohort study aims to investigate the clinical efficacy and safety of Hybrid APC for treatment of gastric low grade intramucosal neoplasia.", "detailedDescription": "This cohort study aims to investigate the clinical efficacy and safety of Hybrid APC for treatment of gastric low grade intramucosal neoplasia. Successful ablation is defined as no evidence of local recurrence at 12 months after HybridAPC upon follow up endoscopy. This is defined as absence of LGIN, HGIN and cancer in biopsies obtained at all locations during followup endoscopy."}, "conditionsModule": {"conditions": ["Gastric Low Grade Intraepithelial Neoplasia"], "keywords": ["Gastric low grade intraepithelial neoplasia", "Hybrid APC", "Endoscopic Ablation"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 100, "type": "ESTIMATED"}}, "armsInterventionsModule": {"armGroups": [{"label": "Hybrid Argon Plasma Coagulation", "type": "EXPERIMENTAL", "description": "The Hybrid-Argon Plasma Coagulation probe combines waterjet technology with Argon Plasma Coagulation. The probe comprises a central water channel for the submucosa injection function and a peripheral gas channel for the Argon Plasma Coagulation function", "interventionNames": ["Procedure: Hybrid Argon Plasma Coagulation"]}], "interventions": [{"type": "PROCEDURE", "name": "Hybrid Argon Plasma Coagulation", "description": "Argon Plasma Coagulation after water injection for local ablation", "armGroupLabels": ["Hybrid Argon Plasma Coagulation"]}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1. Low grade intraepithelial neoplasia of stomach with size\u226420 mm\n2. Endoscopic diagnosis suspected gastric LGIN with biopsy confirmed gastric LGIN\n3. Endoscopic appearance according to Paris classification of Type 0-IIa, IIb or IIc\n4. Patients with informed consent\n\nExclusion Criteria:\n\n1. Patients who had previous endoscopic treatment (including APC, EMR, ESD) for gastric LGIN, HGIN or gastric carcinoma.\n2. Endoscopic evidence of ulcer\n3. Biopsy confirmed HGIN\n4. Endoscopic diagnosis suspected HGIN while biopsy confirmed LGIN\n5. Pregnancy\n6. informed consent not available", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "85 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"centralContacts": [{"name": "Philip WU Chiu, MD", "role": "CONTACT", "phone": "+85235053952", "email": "philipchiu@surgery.cuhk.edu.hk"}, {"name": "Hon Chi Yip, MBChB", "role": "CONTACT", "phone": "+85235052956", "email": "hcyip@surgery.cuhk.edu.hk"}], "overallOfficials": [{"name": "Philip WY Chiu, MD", "affiliation": "Chinese University of Hong Kong", "role": "PRINCIPAL_INVESTIGATOR"}]}}, "hasResults": false}